MRD / Regn No. : 20250000755 Date : 10/06/2026
Patient Name : Hemen Deka Age & Gender : 61 Yrs. / Male
Contact No. : 9365730577 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (29/Sep/2010) | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (29/Sep/2010) | ANEMIA (29/Sep/2025) | A2G3 DKD (29/Sep/2025) |
Subjective : TYPE 2 DM FOR 15 YEARS,ASCVD FOR 15 YEARS,DKD,HAS STOPPED DULAGLUTIDE
Objective : NONE
Analysis : TYPE 2 DM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE,MALENA,A2G3 DKD
Plan : CONTINUE CURRENT MEDICATIONS,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : CREATININE: 1.68 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 44.47 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 105 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.90 % | POST PRANDIAL GLUCOSE (2HPP): 154 mg/dL | UREA: 35 mg/dL | POTASSIUM: 4.8 meQ/L | FERRITIN: 109 | HEMOGLOBIN: 11.5 g/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 12-0-8 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 IN TRULICITY 1.5 MG
DULAGLUTIDE 1.5 MG
ONCE A WEEK BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA
       
Refill : 0 / Substitution:    
Education :
Next Visit : 09/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP BUN CR
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: